HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcello D Bronstein Selected Research

Dopamine Agonists (Dopamine Agonist)

12/2021The effects of cabergoline in the presurgical and recurrence periods of Cushing's disease patients.
2/2020Prolactinomas in pregnancy: considerations before conception and during pregnancy.
12/2018Prolactinomas: how to handle prior to and during pregnancy?
3/2018Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
3/2015Prolactinomas.
12/2014Women with prolactinomas presented at the postmenopausal period.
3/2014[Prolactinoma].
6/2013The place of medical treatment of acromegaly: current status and perspectives.
1/2011Management of pituitary tumors in pregnancy.
9/2010Management of prolactinomas in Brazil: an electronic survey.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcello D Bronstein Research Topics

Disease

31Acromegaly
11/2021 - 08/2005
22Neoplasms (Cancer)
12/2021 - 08/2002
14Pituitary Neoplasms (Pituitary Adenoma)
08/2021 - 01/2006
13Prolactinoma (Prolactinomas)
02/2020 - 08/2002
8Adenoma (Adenomas)
08/2018 - 10/2005
5Pituitary ACTH Hypersecretion
12/2021 - 01/2011
5Hypogonadism (Hypergonadotropic Hypogonadism)
02/2020 - 03/2014
5Hyperprolactinemia
02/2020 - 02/2014
5Carcinogenesis
06/2013 - 10/2005
3Hyperglycemia
12/2020 - 06/2015
2Hypertension (High Blood Pressure)
12/2020 - 06/2015
1Residual Neoplasm
08/2021
1Dyslipidemias (Dyslipidemia)
12/2020
1Pituitary Apoplexy
04/2018
1Birth Weight (Birth Weights)
07/2017
1Stroke (Strokes)
06/2015
1Cushing Syndrome
04/2015
1Menstruation Disturbances
03/2014
1Infertility (Sterility)
03/2014
1Amenorrhea
03/2014
1Autoimmune Hypophysitis
10/2013
1Germinoma
10/2013
1Neurogenic Diabetes Insipidus (Central Diabetes Insipidus)
10/2013
1Obesity
05/2013
1Combined Pituitary Hormone Deficiency
07/2012
1Apnea
01/2012
1Obstructive Sleep Apnea
01/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2010
1Adrenocortical Carcinoma
04/2010
1Growth Hormone-Secreting Pituitary Adenoma
04/2010
1Body Weight (Weight, Body)
07/2008
1Pituitary Diseases (Disease, Anterior Pituitary)
07/2008
1Plexiform Neurofibroma
01/2008
1Nervous System Neoplasms (Neoplasms, Nervous System)
01/2008

Drug/Important Bio-Agent (IBA)

16Dopamine Agonists (Dopamine Agonist)IBA
12/2021 - 08/2002
12Growth Hormone (Somatotropin)IBA
11/2021 - 06/2008
12Octreotide (Sandostatin)FDA LinkGeneric
12/2020 - 08/2005
12ProlactinIBA
12/2018 - 08/2002
10Insulin-Like Growth Factor I (IGF-1)IBA
01/2021 - 07/2008
10Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2017 - 08/2005
6CabergolineFDA LinkGeneric
12/2021 - 05/2008
6pasireotideIBA
12/2020 - 11/2014
6Adrenocorticotropic Hormone (ACTH)FDA Link
06/2015 - 10/2005
6Hormones (Hormone)IBA
10/2013 - 10/2005
5Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 01/2006
5lanreotide (Somatuline)FDA Link
12/2020 - 01/2006
5Pharmaceutical PreparationsIBA
03/2018 - 09/2010
4Estrogens (Estrogen)FDA Link
11/2016 - 01/2007
3Dopamine Receptors (Dopamine Receptor)IBA
12/2021 - 01/2007
3Hydrocortisone (Cortisol)FDA LinkGeneric
12/2021 - 04/2015
3Insulin-Like PeptidesIBA
11/2021 - 11/2014
3LigandsIBA
01/2021 - 05/2015
3Messenger RNA (mRNA)IBA
04/2019 - 01/2007
3Bromocriptine (Parlodel)FDA LinkGeneric
03/2018 - 08/2002
2Insulin (Novolin)FDA Link
10/2019 - 02/2016
2Selective Estrogen Receptor Modulators (SERM)IBA
11/2016 - 05/2015
2GlucocorticoidsIBA
06/2015 - 05/2013
2Pituitary HormonesIBA
12/2014 - 06/2008
2Proteins (Proteins, Gene)FDA Link
04/2010 - 01/2010
2somatostatin receptor type 1IBA
01/2009 - 01/2006
2Estrogen Receptor alphaIBA
01/2009 - 01/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 10/2005
1Biomarkers (Surrogate Marker)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2020
1Sirtuin 1IBA
08/2018
1SirtuinsIBA
08/2018
1Sirtuin 3IBA
08/2018
1amsonic acid (DAS)IBA
03/2018
1polymeric prolactin (BPRL)IBA
03/2018
1Insulin-Like Growth Factor Binding Protein 3IBA
10/2015
1Somatotropin Receptors (Growth Hormone Receptor)IBA
10/2015
1AnticoagulantsIBA
06/2015
1Clomiphene (Clomifene)FDA LinkGeneric
05/2015
1Phosphotransferases (Kinase)IBA
03/2015
1Temozolomide (Temodar)FDA LinkGeneric
03/2015
1Alkylating AgentsIBA
03/2015
1GonadotropinsIBA
12/2014
1Testosterone (Sustanon)FDA Link
03/2014
1Tumor Biomarkers (Tumor Markers)IBA
10/2013
1Transcription Factors (Transcription Factor)IBA
06/2013
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
05/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2013
1Ketoconazole (Nizoral)FDA LinkGeneric
01/2011
1MetyraponeFDA Link
01/2011
1DNA (Deoxyribonucleic Acid)IBA
04/2010
1aryl hydrocarbon receptor-interacting proteinIBA
04/2010
1pegvisomantFDA LinkGeneric
01/2010
1Estrogen Receptor betaIBA
01/2009
1Nerve Growth Factor (NGF)IBA
01/2009
17- O- (2- amino- 2- deoxyglucopyranosyl)heptoseIBA
07/2008
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
06/2008
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
06/2008
1Follicle Stimulating Hormone (Follitropin)FDA Link
06/2008
1Progesterone Receptors (Progesterone Receptor)IBA
01/2008
1Estrogen ReceptorsIBA
01/2008

Therapy/Procedure

21Therapeutics
08/2021 - 08/2002
8Radiotherapy
12/2021 - 08/2002
1Conservative Treatment
04/2018
1Aftercare (After-Treatment)
10/2015
1Continuous Positive Airway Pressure
01/2012